HELP is Cybin Inc. Common Stock (Healthcare) — a non-dividend-paying stock. Trading at $12.22. Market cap: $893M.
Stock snapshot
| Price | $12.22 |
| Market cap | $893M |
| Sector | Healthcare |
| Exchange | XNAS |
| Pays dividend | No |
About HELP
Helus Pharma Inc, the commercial operating name of Cybin Inc, is a clinical-stage pharmaceutical company focused on developing proprietary neuroactive compounds, referred to as NSAs, which are synthetic molecules designed to target serotonin pathways. The company's programs are aimed at treating mental health conditions such as depression and anxiety. Its pipeline includes HLP003, which is in clinical development for the adjunctive treatment of depressive disorder, and HLP004, which is in clinical development for generalized anxiety disorder. The company also conducts research on additional investigational compounds.
Related non-dividend companies
Other non-dividend stocks investors research alongside HELP. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is HELP's current stock price?
HELP (Cybin Inc. Common Stock) is currently trading at $12.22.
Does HELP pay a dividend?
HELP (Cybin Inc. Common Stock) does not currently pay a regular dividend.
Track HELP in DiviDrip
Add HELP to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search HELP and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-05. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.